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Cutaneous Denervation of Psoriasiform Mouse Skin
Improves Acanthosis and Inflammation in a Sensory
Neuropeptide-Dependent Manner
Stephen M. Ostrowski1,2,4, Abdelmadjid Belkadi1,4, Candace M. Loyd2,4, Doina Diaconu2 and
Nicole L. Ward1,2,3
Nervous system involvement in psoriasis pathogenesis is supported by increases in nerve fiber numbers and
neuropeptides in psoriatic skin and by reports detailing spontaneous plaque remission following nerve injury.
Using the KC-Tie2 psoriasiform mouse model, we investigated the mechanisms by which nerve injury leads to
inflammatory skin disease remission. Cutaneous nerves innervating dorsal skin of KC-Tie2 animals were
surgically axotomized and beginning 1 day after denervation, CD11cþ cell numbers decreased by 40% followed
by a 30% improvement in acanthosis at 7 days and a 30% decrease in CD4þ T-cell numbers by 10 days.
Restoration of substance P (SP) signaling in denervated KC-Tie2 skin prevented decreases in CD11cþ and CD4þ
cells, but had no effect on acanthosis; restoration of calcitonin gene–related peptide (CGRP) signaling reversed
the improvement in acanthosis and prevented denervated-mediated decreases in CD4þ cells. Under innervated
conditions, small-molecule inhibition of SP in KC-Tie2 animals resulted in similar decreases to those observed
following surgical denervation for cutaneous CD11cþ and CD4þ cell numbers; whereas small-molecule
inhibition of CGRP resulted in significant reductions in CD4þ cell numbers and acanthosis. These data
demonstrate that sensory nerve-derived peptides mediate psoriasiform dendritic cell and T-cell infiltration and
acanthosis and introduce targeting nerve-immunocyte/KC interactions as potential psoriasis therapeutic
treatment strategies.
Journal of Investigative Dermatology (2011) 131, 1530–1538; doi:10.1038/jid.2011.60; published online 7 April 2011
INTRODUCTION
Psoriasis is a complex, multifaceted disease whose pathogen-
esis has not been fully elucidated. Whereas great advances
have been made in understanding the roles of the immune
system and the epidermal components of this skin disease,
the contribution of the cutaneous neural system remains
underexplored. Numerous observations suggest that the
nervous system may play a role in this disease, including
the symmetrical distribution of plaque on the body, likely
reflective of peripheral sensory nerve interactions with
immunomodulatory networks (Farber et al., 1986); the
observation that emotional stress is often linked to onset
and/or exacerbation of psoriasis (Seville, 1977); the increase
in nerve fibers and their secreted neuropeptides in involved
psoriatic skin (for a review, Saraceno et al., 2006), and the
striking finding that psoriasis undergoes remission following
nerve transection, nerve injury, or decreased nervous system
functioning (Dewing, 1971; Perlman, 1972; Farber et al.,
1990; Stratigos et al., 1998; Joseph et al., 2005).
Published animal models of psoriasis have failed to report
increases in cutaneous nerve numbers and/or density or
changes in neuropeptide expression (Gudjonsson et al.,
2007), resulting in limited opportunity to study the role of
nerves and their derived factors in preclinical models of
psoriasis. We recently reported the generation and character-
ization of a KC-Tie2 murine model of psoriasiform skin
disease, based on keratinocyte (KC)-specific expression of the
angiopoietin receptor Tie2 (Wolfram et al., 2009). Although
Tie2 is not normally expressed in human KCs, ectopic
expression of Tie2 in KCs initiates cellular events resulting in
a skin phenotype that resembles many characteristics of
human psoriatic disease, including the increased presence of
CD4þ and CD8þ T cells, CD11cþ and F4/80þ myeloid-
derived cells, a psoriasis-like cytokine and chemokine
profile, and responsiveness to clinically efficacious therapeu-
tics such as cyclosporin A (Wolfram et al., 2009) and tumor
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necrosis factor-a inhibition (Ward et al., 2010). Moreover,
genomic expression changes in involved KC-Tie2 mouse skin
highly correlate with genomic expression changes identified
in involved human psoriatic skin (Swindell et al., 2011).
Recently, we reported the increased presence of cutaneous
nerves in KC-Tie2 mouse skin (Ward et al., 2011), thereby
providing a unique preclinical model to test the contributions
and significance of the cutaneous neural cell population in
sustaining psoriasiform skin inflammation.
RESULTS
KC-Tie2 mice have increased neuropeptide expression in skin
and dorsal root ganglia
We previously reported increases in cutaneous nerve fiber
numbers in KC-Tie2 mouse skin (Ward et al., 2011). Using
quantitative reverse transcription–PCR, we examined neuro-
peptide mRNA expression levels in KC-Tie2 mouse skin and
identified a 4.1-fold increase in substance P (SP; P¼0.07) and
a 9.2-fold increase in neuropeptide Y (Po0.001; Figure 1a)
and no differences in expression of vasoactive intestinal
peptide, somatostatin, or calcitonin gene–related peptide
(CGRP). However, skin-derived neuropeptide expression does
not reflect nerve specificity, as other skin cells synthesize these
molecules. Nerve-derived factors are synthesized in the
neuronal cell body (located in the dorsal root ganglia) and
are anterogradely transported to the skin where they are
secreted and exert their effects; therefore dorsal root ganglia
from the thoracic region of KC-Tie2 and littermate control
animals were dissected and mRNA expression of the same
neuropeptides was examined. No statistically significant
changes in vasoactive intestinal peptide, neuropeptide Y, or
somatostatin expression were found; however, expression
of SP (3.7-fold, Po0001) and CGRP (3.6-fold, Po0.0002;
Figure 1b) were significantly increased in KC-Tie2 mice.
Surgical cutaneous denervation results in loss of PGP9.5þ
nerves and significant improvement of acanthosis in KC-Tie2
animals
We developed surgical denervation procedures for transect-
ing the thoracic-level cutaneous nerves at their entry site into
back skin. Using this approach, one side of mouse back skin
was denervated, whereas the contralateral side underwent
sham surgery, leaving the nerves intact (Supplementary
Figure S1a–c online), allowing the direct comparison of the
psoriasiform phenotype in the presence or absence of nerves
in the same animal. A complete loss of detectable protein
gene product 9.5 (PGP9.5þ ) nerve fiber immunofluorescence
staining was apparent beginning 7 days postdenervation and
remained apparent until 10 days (Supplementary Figure S1c
online). Analysis was limited to 10 days postdenervation, as
beyond 10 days PGP9.5þ nerve staining reappeared, likely
reflective of collateral reinnervation through sprouting of
nerves from adjacent dermatomes (Kinnman, 1987)—a
finding consistent with what others have reported (Siebenhaar
et al., 2008). Western blotting confirmed the decrease in
PGP9.5 protein levels 7–10 days postdenervation (Supple-
mentary Figure S1d online), although small residual levels of
PGP9.5 protein remained, most likely due to expression by
non-neural tissues, including dendritic cells (DCs; Stankovic
et al., 1999) and Merkel cells (Casasco et al., 1990).
Ten days after unilateral surgical denervation, KC-Tie2
mouse skin showed a 34% decrease (Po0.0001) in acanthosis
on the denervated side compared with the contralateral
innervated control side (Figure 2), consistent with published
reports detailing the spontaneous remission of psoriasis in
humans following loss of cutaneous nerve innervation
(Dewing, 1971; Farber et al., 1990; Joseph et al., 2005).
Moreover, a marked reduction in the cellular proliferation
marker Ki67 was observed in KCs of denervated KC-Tie2 skin
compared with sham-operated skin (Figure 2e–f).
Immunocytes and IL-23 protein expression are reduced in
denervated skin
To identify potential mechanisms underlying the improve-
ment in acanthosis following denervation, we examined
changes in immune cell presence and angiogenesis between
innervated and denervated skin. Ten days after surgical
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Figure 1. KC-Tie2 mice have increased expression of neuropeptides in skin
and dorsal root ganglia (DRG) than control mice. Real-time PCR was
performed using primers targeting the neuropeptides somatostatin (SST),
substance P (SP), calcitonin gene-related peptide (CGRP), vasoactive
intestinal peptide (VIP), and neuropeptide Y (NPY). (a) KC-Tie2 animals (n¼ 4)
have increased levels of SP and NPY expression in whole back skin as
compared with control animals (n¼ 4) and (b) increased level of SP and CGRP
expression in their DRGs as compared with control animals. P values are as
indicated.
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denervation, the number of cutaneous macrophages and mast
cells remained unchanged between sham-operated and
denervated skin (Supplementary Figure S2a and b online).
However, a decrease (16%, P¼ 0.01) in the number of
cutaneous CD4þ T cells was identified (Figure 3a–d). Despite
this decrease, IFN-g, IL-17, and IL-6 protein expression
remained constant in denervated skin as compared with sham
skin (Figure 3e–g).
The most striking observation was a 50% decrease in the
number of dermal CD11cþ cells in denervated skin, represent-
ing a return to levels comparable to those in innervated
littermate (non-KC-Tie2) controls (Figure 4a–d). DCs are potent
producers of IL-23, and ELISA analyses revealed a 33%
decrease in IL-23 protein expression in whole-skin lysates
isolated from denervated KC-Tie2 mouse back skin compared
with sham-operated innervated skin (Figure 4e).
Examination of the dermal vasculature revealed no
changes in the number of dermal blood vessel numbers
(Supplementary Figure S3a online) or in IGF-1 or VEGF
protein (Supplementary Figure S3b and c online).
Decreases in CD11cþ cell numbers precede improvements in
acanthosis and reductions in CD4þ T-cell numbers
To determine the temporal sequence of events following
surgical denervation, parallel cohorts of KC-Tie2 animals
underwent surgical denervation on the same day, and
changes to acanthosis and CD11cþ and CD4þ cell numbers
were quantitated 1, 3, 5, 7, and 10 days after surgery.
CD11cþ cell numbers decreased significantly beginning
1 day after surgery (P¼0.011), and this decrease was sustained
over 10 days (P¼0.016). Acanthosis improvements did not
become significant until day 7 (P¼ 0.019), whereas CD4þ cell
numbers were significantly decreased 10 days after denerva-
tion (P¼ 0.029; Supplementary Table S1 online).
SP and CGRP receptor agonist administration into denervated
skin reverses CD11cþ and CD4þ T-cell improvements and
acanthosis in a neuropeptide-specific manner
To identify the significance of SP and CGRP contributions to
the denervation-mediated outcomes observed in KC-Tie2
skin, intradermal injections of CGRP peptide, the SP receptor
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Figure 2. Surgical denervation of KC-Tie2 mouse skin results in decreased acanthosis. Representative images of hematoxylin and eosin staining of sections of
(a) control, (b) KC-Tie2 sham-operated, and (c) KC-Tie2 denervated back skin. (d) Epidermal thickness (in mM) of the sham-operated side and the denervated
side of back skin is presented for individual animals (n¼13). The hatched line represents average epidermal thickness levels in innervated control mouse
back skin. Representative images of Ki67 stained sections of (e) KC-Tie2 sham-operated and (f) KC-Tie2 denervated back skin. P values are as indicated.
Scale bar¼ 50 mM.
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agonist (GR73632; peptide agonist of NK-1R), or phosphate-
buffered saline (PBS) were administered into the region of
denervated skin daily for a 10-day period following denerva-
tion. Doses and administration routes were chosen on the
basis of previous reports showing in vivo effectiveness in
mediating biological responses in skin (Fuller et al., 1987;
Niizeki et al., 1999). Introduction of PBS or the SP receptor
agonist (GR73632) into denervated skin failed to alter the
denervation-mediated improvement in acanthosis (P¼0.04
sham vs. denervatedþPBS; P¼ 0.05 sham vs. denerva-
tedþGR73632); however introduction of CGRP peptide into
denervated skin markedly blunted the effect of denervation
on acanthosis. CGRP-treated denervated skin was signifi-
cantly thicker than denervatedþPBS- (P¼ 0.012) and dener-
vatedþGR73632-treated skin (P¼0.013; Figure 5a);
however, the reversal of acanthosis following CGRP peptide
treatment was not absolute, as CGRP-treated denervated skin
remained slightly thinner than control sham-operated in-
nervated skin (P¼0.03). Examination of Ki67 expression
showed similar staining between sham and denervated skin
treated with CGRP peptide (Supplementary Figure S4e and f
online) but remained decreased in denervated skin treated
with PBS or GR73632 (Supplementary Figure S4a–d online)
compared with sham-operated skin.
Examination of CD4þ T-cell numbers in denervated skin
treated with PBS confirmed the reduction in T-cell numbers
following denervation (P¼ 0.001). Following intradermal
injections of CGRP peptide or the SP receptor agonist
(GR73632), CD4þ cell numbers returned to sham-operated,
innervated skin levels (Figure 5b).
CD11cþ cell numbers in denervated skin were not
affected by treatment with PBS (P¼ 0.01) or with CGRP
peptide (P¼0.034); however, administration of the SP
receptor agonist GR73632 returned CD11cþ cell numbers
to sham-operated, innervated skin levels (Figure 5c).
SP and CGRP receptor antagonist administration to innervated
skin mimics denervation-mediated improvements in immune-
cell infiltration and acanthosis in a neuropeptide-specific
manner
To confirm key functions for SP and CGRP in maintaining the
psoriasiform skin phenotype in KC-Tie2 animals, we exam-
ined acanthosis and immune-cell infiltration following
treatment with either RP67580, a well-characterized SP
receptor antagonist (Arck et al., 2003), or CGRP8–37, a well-
characterized selective CGRP receptor antagonist (Legat
et al., 2004; Costa et al., 2008). Innervated KC-Tie2 mice
were treated with RP67580 every other day or with CGRP8–37
or PBS daily for a period of 30 days, a time point we
previously showed was sufficient to reverse acanthosis and
inflammation (Wolfram et al., 2009; Ward et al., 2010).
Examination of the skin revealed no changes in epidermal
thickness or Ki67 immunostaining after treatment with PBS or
RP67580 but a significant improvement in acanthosis and
decreases in Ki67 staining in mice treated with CGRP8–37,
reminiscent of what was observed following cutaneous
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Figure 3. CD4þ T-cell numbers decrease in denervated skin, whereas T cell–derived cytokines remain unchanged. (a–c) Representative images of CD4
immunohistochemical staining in back skin sections of (a) control, (b) KC-Tie2 sham-operated, and (c) KC-Tie2-denervated back skin. (d) CD4þ T-cell numbers
in sham-operated skin and denervated skin are presented for individual animals and are significantly decreased in KC-Tie2-denervated mouse skin compared
with sham-operated skin (n¼ 10). The hatched line represents average number of CD4þ T cells in back skin of control mice. Western blotting (e) and ELISA
(f and g) demonstrate no changes in IFN-g, IL-17, and IL-6 between sham-operated and denervated KC-Tie2 mouse skin. P values are as indicated. GAPDH,
glyceraldehyde-3-phosphate dehydrogenase. Scale bar¼ 50 mM.
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surgical denervation (P¼ 0.009; Figure 6a; Supplementary
Figure S4g–i online). Examination of CD4þ cell numbers
revealed significant decreases in dermal T-cell numbers in
KC-Tie2 mice that were treated with either RP67580
(P¼0.03) or CGRP8–37 (P¼0.01) but not PBS (Figure 6b).
Finally, significant reductions in the CD11cþ cell population
were observed only following treatment with the SP receptor
antagonist (RP67580; P¼ 0.001) and not PBS or CGRP8–37
(Figure 6c).
DISCUSSION
Psoriasis has primarily been thought of as a disease driven by
abnormal interactions between KCs and inflammatory
immunocytes. However, clinical evidence suggests that the
nervous system also plays a key role in psoriasis pathogen-
esis. Using the KC-Tie2 murine model of psoriasis, we
confirmed significant increases in SP and CGRP mRNA in
KC-Tie2 dorsal root ganglia, a finding that supports reports of
increases in SPþ and CGRPþ sensory nerve numbers in
involved skin of psoriasis patients (Saraceno et al., 2006). We
then developed an experimental approach resulting in loss of
cutaneous innervation, thereby allowing us to mimic several
case reports describing spontaneous psoriasis remission
following nerve injury (Dewing, 1971; Farber et al., 1990;
Joseph et al., 2005). This loss of cutaneous innervation
resulted in robust and reproducible improvements in
acanthosis, decreases in CD4þ T cells, and an elimination
of CD11cþ cells concomitant with decreased IL-23 protein
expression, thereby providing an experimental preclinical
model mimicking case and anecdotal reports detailing
spontaneous psoriasis remission following nerve injury.
The rapid decrease in CD11cþ cells following denerva-
tion suggests that nerve-derived factors signal directly to
CD11cþ cells in KC-Tie2 skin. Interestingly, in mouse
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Figure 4. Surgical denervation of KC-Tie2 mouse skin reduces CD11cþ
dendritic cell numbers back to control mouse levels and decreases IL-23
protein expression. (a–c) Representative images of CD11cþ
immunohistochemical staining in back skin sections of (a) control, (b) KC-Tie2
sham-operated, and (c) KC-Tie2-denervated back skin. (d) CD11cþ cell
numbers in sham-operated skin and denervated skin are presented for
individual animals (n¼ 11). The hatched line represents average number of
CD11cþ cells in back skin of control mice. (e) ELISA analysis of IL-23 protein
expression demonstrates a significant decrease in denervated skin compared
with sham-operated skin in KC-Tie2 mice. P values are as indicated.
Scale bar¼ 50 mM.
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Figure 5. Restoration of neuropeptide signaling under denervated conditions
returns CD11cþ and CD4þ cell numbers and acanthosis back to innervated
conditions in a neuropeptide-specific manner. Epidermal thickness (a),
CD4þ cell number (b), and CD11cþ cell number (c) are presented for cohorts
of animals (n¼ 4 per group) that had phosphate-buffered saline (PBS),
substance P receptor agonist (GR73632), or calcitonin gene-related peptide
(CGRP) peptide injected intradermally into the denervated side of the back
skin daily beginning 1 day after surgery. P values are as indicated.
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models of neurogenic stress, reports indicate that there are
increased levels of SP and increased numbers of CD11cþ
DCs in the dermis (Joachim et al., 2008). Thus, it is tempting
to speculate that signaling by SP in KC-Tie2 mouse skin
contributes to cutaneous DC infiltration, and that denervation
reduces CD11cþ cell recruitment through downregulation of
SP signaling. Supporting this idea were the findings that
addition of the SP agonist (GR73632) under denervated
conditions resulted in a restoration of the CD11cþ popula-
tion in the dermis and that inhibition of SP signaling by
treatment with the SP receptor-NK-1R antagonist (RP67580)
led to decreased CD11cþ numbers in innervated KC-Tie2
mouse skin.
CGRP has well-known effects on antigen-presenting cells
and has been shown to inhibit antigen presentation through
modulation of cAMP signaling as well as to modulate
cytokine production through inhibition of NF-kB activation
(Hosoi et al., 1993; Torii et al., 1998; Ding et al., 2007). Our
data demonstrate that introduction of exogenous CGRP to
denervated KC-Tie2 skin failed to return CD11cþ cell
numbers back to levels observed under innervated condi-
tions. Supporting this was the lack of effect on CD11cþ DC
numbers in innervated KC-Tie2 mouse skin following
treatment with the CGRP receptor antagonist, CGRP8–37,
suggesting that in our model CGRP likely does not play a
significant role in recruitment of CD11cþ cells to the skin.
Interestingly, although we observed significant decreases
in acanthosis following denervation, we failed to see
complete resolution of acanthosis, consistent with the idea
that non-neural systems are significant contributors to
sustaining disease. Alternatively, it is plausible that with
additional time beyond the 10-day period, a more complete
resolution in acanthosis could be observed; however,
analysis beyond the 10-day time point was not feasible using
the current model system because of collateral sprouting of
adjacent nerves that re-innervate the skin. In both the SP
inhibition and SP restoration experiments, SP had no effect on
acanthosis, suggesting that, although SP may serve as a key
mediator of neural-DC interactions and sustainment of the
psoriasiform phenotype in KC-Tie2 mice, other nerve-derived
factors must contribute to acanthosis. Interestingly, animal
experiments in which normal mouse skin was denervated
have previously reported thinning of the epidermis and
decreases in KC proliferation (Chiang et al., 1998; Hsieh and
Lin, 1999; Huang et al., 1999), suggesting the potential for
direct interaction between KC proliferation and nerve
innervation, although contributions of the immune system
were not examined. Direct interactions between nerves and
KCs are supported by in vitro findings of others that
demonstrate that CGRP is capable of directly influencing
KC proliferation (Seike et al., 2002; Yu et al., 2009). This
supports the idea that KC proliferation and epidermal
hyperplasia present in psoriasis may occur as a direct effect
of nerve-derived CGRP on the KCs themselves, and once the
neural-derived influences are lost following denervation,
acanthosis improves as a result of less KC proliferation. The
observation that exogenous CGRP introduction into dener-
vated skin (and not SP agonist) returned acanthosis and KC
proliferation levels close to those observed in innervated KC-
Tie2 skin provides support for this concept and, taken
together with the receptor antagonist experimental findings
demonstrating that CGRP (and not SP) inhibition in inner-
vated skin resulted in significant decreases in acanthosis to
the same degree as surgical denervation, identifies CGRP as a
critical nerve-derived peptide capable of mediating KC
proliferation and epidermal hyperplasia. Although SP has
been shown in some reports to stimulate proliferation of
KCs in culture (Tanaka et al., 1988), we failed to see any
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Figure 6. Inhibition of substance P (SP) or calcitonin gene-related peptide
(CGRP) activity under innervated conditions mimics denervated-mediated
changes to acanthosis and CD11cþ and CD4þ cell numbers in a
neuropeptide-specific manner. Epidermal thickness (a), CD4þ cell number
(b), and CD11cþ T-cell number data (c) are presented for cohorts of animals
(n¼4–6 per group) before (pretreatment) and after (posttreatment) 30 days of
treatment with either phosphate-buffered saline (PBS), the selective SP
receptor–NK-1R antagonist (RP67580), or the CGRP antagonist, CGRP8–37.
P values are as indicated.
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SP-mediated effects on acanthosis or KC proliferation in our
model. This may be due to a lack of SP effects on KC
proliferation in vivo or may reflect more complex interactions
of SP with other peptides and cell types intrinsic to studying
biological actions in an in vivo model system. Although
decreased acanthosis following denervation may be due to
direct effects of nerve-derived factors on KCs, it also possible
that acanthosis is secondary to immune modulation.
CD4þ T cells decreased in number following denervation
only after decreases in CD11cþ cell numbers and improve-
ment in acanthosis were noted. Given that both CD11cþ
cells and KCs produce proinflammatory cytokines that
contribute to T-cell infiltration and activation, such as IL-23
(Lee et al., 2004; Zheng et al., 2007), it is likely that both also
contribute to the decrease in T-cell numbers observed in
denervated skin. Alternatively, nerve-derived factors have the
capacity to function directly on T cells; CGRP is capable of
stimulating CD4þ cell migration in vitro (Talme et al., 2008),
and SP can bind to its receptor, NK-1R, which has been
shown to be important for leukocyte accumulation in a
model of tumor necrosis factor-a–induced cutaneous inflam-
mation (Costa et al., 2006). However, significant T-cell
decreases were not apparent until 10 days after denervation,
making a direct mechanism less likely in our model. The
decrease in CD4þ cells postdenervation, albeit small, was
statistically different; however, T cell–derived cytokines
remained unchanged in their expression (IL-6, IFN-g, and
IL-17), potentially explaining the lack of complete resolution
of acanthosis in denervated skin. It remains possible that
further decreases in T-cell numbers and/or their derived
cytokines would occur beyond the 10-day period postax-
otomy, resulting in further acanthosis resolution.
Although SP and CGRP are some of the most well-
characterized nerve-derived substances in psoriasis (Saraceno
et al., 2006) and in neurogenic inflammation (Peters et al.,
2005, 2007; Arck et al., 2006; Joachim et al., 2008; Pavlovic
et al., 2008), other nerve-derived compounds may also play
roles. Norepinephrine, as one example, has been suggested to
potentially play a role in skin inflammation (Saint-Mezard
et al., 2003), such that it can decrease differentiation of CD4þ
T cells and can regulate human DC and Langerhans cell
functions in the skin (Seiffert et al., 2002; Goyarts et al., 2008).
Nerve growth factor, a KC-derived growth factor, is
upregulated along with its receptors in human psoriatic skin
(Raychaudhuri and Raychaudhuri, 2004) and is critical at the
early stages of plaque development, preceding T lymphocyte
trafficking into the epidermis (Raychaudhuri et al., 2008);
and, when inhibited, can lead to resolution of skin
inflammation in the SCID psoriasis mouse model (Raychaud-
huri et al., 2004). Nerve growth factor can also increase the
percentage of SPþ and CGRPþ nerve fibers in the dorsal root
ganglia and skin (Joachim et al., 2007). In established plaque
from KC-Tie2 animals, nerve growth factor expression is
unchanged compared with that in control animals (data not
shown), despite increases in the number of cutaneous nerves
and nerve-derived SP and CGRP. Future work examining
the effects of denervation on the ability to initiate
plaque formation using murine models of psoriasiform skin
inflammation in which nerve growth factor is known to play a
crucial role (such as the imiquimod model (van der Fits et al.,
2009) may provide further insight into this bidirectional
relationship.
In conclusion, we have demonstrated that the KC-Tie2
model contains neural alterations seen in psoriasis and that
the epidermal and immunological features of this model are
dependent on innervation of the skin. As a result of direct and
indirect cellular interactions, ablation of nerve-derived
signals results in decreased DC numbers, IL-23 and T-cell
infiltration, and improved acanthosis, similar to what we
observed following Tie2 gene repression, cyclosporin A
treatment, antigen-presenting cell depletion, and tumor
necrosis factor-a inhibition (Wolfram et al., 2009; Ward
et al., 2010) and what has been observed in human skin after
efficacious treatment with tumor necrosis factor-a inhibitors
(Gottlieb et al., 2005; Zaba et al., 2007), anti-CD11a (Lowes
et al., 2005), anti-CD2 (Chamian et al., 2005), and anti-IL12/
23p40 (Papp et al., 2008; Griffiths et al., 2010) treatment.
These preclinical findings provide evidence that the signals
from the nervous system—specifically, nerve-derived SP and
CGRP—sustain psoriasis, and that targeting the nervous
system may be a therapeutic option.
MATERIALS AND METHODS
Please refer to Supplementary Materials and Methods online for a
detailed and extensive description of experimental procedures used.
Transgenic mice and surgical axotomy of thoracic cutaneous
nerves
All animal protocols were approved by the Case Western Reserve
University institutional animal care and use committee and conformed
to the American Association for Accreditation of Laboratory Animal
Care guidelines. KC-Tie2 mice were generated as described previously
(Wolfram et al., 2009) and in detail in the Supplementary Methods
online. Cutaneous denervation surgery was adapted from previously
described techniques (Siebenhaar et al., 2008) and is described in
detail in the Supplementary Methods online.
In vivo neuropeptide inhibitor and agonist experimental
approach
For SP and CGRP inhibitor experiments under innervated conditions
and SP and CGRP agonist experiments under denervated conditions,
2-month-old KC-Tie2 mice were used, and dosing and administra-
tion details were completed as detailed in the Supplementary
Materials and Methods online. For agonist and antagonist experi-
ments, dosing and administration routes were chosen on the basis of
previous reports showing in vivo effectiveness in mediating
biological responses in skin (Fuller et al., 1987; Niizeki et al.,
1999; Arck et al., 2003; Legat et al., 2004; Costa et al., 2008). For
each animal, a pretreatment biopsy was taken; thus, each animal
served as its own control.
Tissue collection and histological and morphometric analyses
Tissue collection, hematoxylin and eosin and toluidine blue staining,
and morphometric analyses were completed as described previously
(Wolfram et al., 2009) and in detail in the Supplementary Methods
online.
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Antibody detection, visualization, and quantitation of CD4þ ,
CD11cþ , F4/80þ , MECA-32þ , and Ki67þ cells were completed as
described previously (Ward et al., 2010) and in detail in the
Supplementary Methods online.
Immunofluorescence against PGP9.5 was performed and quanti-
tated as described previously (Ward et al., 2011) and in detail in the
Supplementary Methods online.
Protein isolation and analyses and RNA isolation and
quantitation
Analyses of protein and RNA from back skin taken from adjacent
areas of innervated and denervated skin from the same mice as used
for histology, immunohistochemistry, and immunofluorescence
were completed as described previously (Wolfram et al., 2009)
and in detail in the Supplementary Methods online.
Statistical analysis
All data are presented as mean±SEM. Control versus KC-Tie2
animal data and comparison between different treatment groups was
analyzed using an unpaired Student’s t-test, whereas innervated
versus denervated comparisons within the same animal were
analyzed using a paired Student’s t-test. Statistical significance was
defined as Po0.05.
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